BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1395942)

  • 1. [HLA and acetylcholine receptor antibody in patients with myasthenia gravis].
    Xu W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Jun; 25(3):150-3, 190-1. PubMed ID: 1395942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association of HLA BW46 with juvenile onset myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Chan-Lui WY; Choi EK; Ho AY
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):555-7. PubMed ID: 6588146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
    Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
    Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on myasthenia gravis in children with HLA supratype].
    Zhang XG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):358-60, 385. PubMed ID: 1305001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA antigens with myasthenia gravis in Chinese on Taiwan.
    Chiu HC; Hsieh RP; Hsieh KH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Feb; 23(1):12-8. PubMed ID: 2394179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
    Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
    Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome.
    Kojima Y; Uzawa A; Ozawa Y; Yasuda M; Onishi Y; Akamine H; Kawaguchi N; Himuro K; Noto YI; Mizuno T; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):963-968. PubMed ID: 33766920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immunoglobulin secretion by lymph organs with myasthenia gravis.
    Yoshikawa H; Satoh K; Yasukawa Y; Yamada M
    Acta Neurol Scand; 2001 Jan; 103(1):53-8. PubMed ID: 11153889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan.
    Huang YC; Yeh JH; Chiu HC; Chen WH
    J Formos Med Assoc; 2008 Jul; 107(7):572-5. PubMed ID: 18632417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at sampling and sex distribution of AChRAb vs. MuSKAb myasthenia gravis in a large Greek population.
    Belimezi M; Kalliaropoulos A; Jiménez J; Garcia I; Mentis AA; Chrousos GP
    Clin Neurol Neurosurg; 2021 Sep; 208():106847. PubMed ID: 34343914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis.
    Yoshikawa H; Lennon VA
    Neurology; 1997 Aug; 49(2):562-7. PubMed ID: 9270597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of HLA in clinical courses of myasthenia gravis.
    Hayashi M; Kida K; Yamada I; Matsuda H; Sonoda S; Inoue H; Shiga S
    J Neuroimmunol; 1988 May; 18(2):171-9. PubMed ID: 3356802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the cut-offs in acetylcholine receptor antibodies and diagnostic performance in myasthenia gravis patients.
    Shao K; Yue YX; Zhao LM; Hao HJ; Ding XJ; Jiang P; Yan CZ; Li HF
    Clin Chim Acta; 2022 Aug; 533():122-130. PubMed ID: 35750085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis in Chinese children.
    Chan-Lui WY; Leung NK; Lau TT
    Dev Med Child Neurol; 1984 Dec; 26(6):717-24. PubMed ID: 6519356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seronegative myasthenia gravis].
    Bilińska M
    Pol Merkur Lekarski; 2002 Jan; 12(67):49-53. PubMed ID: 11957803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes.
    Katzberg HD; Aziz T; Oger J
    J Neurol Sci; 2002 Oct; 202(1-2):77-83. PubMed ID: 12220697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.